Withings has been making connected health devices since 2009, and in 2026, the French company is putting out some of its most technically serious work yet. The brand now serves over 15 million users across 40 countries, and its product lineup has grown well beyond smart scales. From FDA-cleared at-home stethoscopes to longevity-focused body scanners, Withings is expanding what home health monitoring can actually measure.
For anyone thinking about investing in a personal health setup, the current Withings ecosystem covers more ground than most people realize.
The BeamO Changes Things:
BeamO received FDA clearance in November 2025, combining an electrocardiogram, a digital stethoscope, a contactless thermometer, and an SpO2 oximeter into one device. It retails for $249.95 and completes all three tests in under a minute.
BeamO became available in the EU in April 2025 and launched in the US in November 2025. It connects to the Withings app and supports telehealth use, letting users share measurement data directly with a doctor during or after a virtual consultation. For families managing ongoing health conditions or anyone who lives far from a clinic, this is a genuinely practical device.
Body Scan 2 at CES 2026:
Withings unveiled the Body Scan 2 at CES 2026, a smart scale that tracks over 60 longitudinal biomarker measurements. It adds Impedance Cardiography to monitor heart pumping efficiency and Bioimpedance Spectroscopy to assess cellular health and metabolic function, building on the original Body Scan from 2023.
The Body Scan 2 is priced at $599.95 and is expected to launch in Q2 2026, pending FDA clearance for its heart metrics. The original Body Scan remains available at $399. Users receive a Health Trajectory score that synthesizes biomarker data into a single metric. The most extensive scans take up to 90 seconds, and tracking happens automatically each time a user steps on the scale. Health data is stored in compliance with both HIPAA and GDPR standards.
For buyers who already track fitness metrics and want deeper insight into cardiovascular and metabolic health over time, the Body Scan 2 is the most comprehensive at-home scale Withings has produced.
ScanWatch 2 and Wrist-Based Tracking:
ScanWatch 2 is a hybrid smartwatch that passively detects signs of AFib through Irregular Rhythm Notifications. It uses a HRV-based Vitalité Indicator that accounts for heart rate variability, temperature, respiratory rhythm, recovery, and effort to give a daily picture of energy and wellness.
The watch pairs well with the Withings app and the Cardio Check-Up service, which connects users with board-certified cardiologists within 24 hours for a detailed cardiovascular health review. The service is available through the Withings+ subscription and is powered by Heartbeat Health in the US and DPV Analytics in France and Germany.
ScanWatch 2 sits at the intersection of classic watch design and medical-grade sensing. It does not look like a fitness tracker, which matters to users who want health monitoring without sacrificing how a watch looks on the wrist.
BPM Vision for Blood Pressure:
The BPM Vision launched in the US after receiving FDA clearance, priced at $149.95. It features a 2.8-inch color screen, interchangeable cuffs for different arm sizes, and supports up to 8 user profiles, making it practical for shared household use.
The accuracy of BPM Vision was validated in a clinical trial involving 91 subjects, and the device follows ACC/AHA hypertension guidelines, categorizing results using color-coded feedback across five blood pressure ranges. Readings sync to the Withings app via Wi-Fi automatically, with no need to open a phone after initial setup.
For households managing hypertension or tracking cardiovascular health between doctor visits, the BPM Vision is one of the cleaner home blood pressure solutions currently available. It sits above basic cuff monitors in terms of data clarity and app integration.
The Withings+ Subscription Layer:
Almost every Withings device becomes more useful when paired with Withings+, which runs at $99.50 per year. The subscription unlocks the Cardio Check-Up service, daily health coaching, and trend analysis across connected devices. Users get up to four cardiologist ECG reviews per year included.
The subscription model also creates continuity across the product line. Someone using a Body Scan 2, a ScanWatch 2, and a BPM Vision can view all data in one place, track trends over months, and share structured health records with a doctor. That kind of consolidated view is useful for anyone managing a specific condition or working with a healthcare provider on preventive care. For more on health wearables that support clinical-grade monitoring, explore the Withings ScanWatch 2 review for an in-depth look at wrist-based tracking.
Who the Withings Ecosystem Suits:
Withings devices target people who want medical-grade data at home, not just fitness metrics. The lineup suits adults managing cardiovascular conditions, people in preventive health routines, and families who want a shared health monitoring setup at home. The devices also cover a range of price points, from the $149.95 BPM Vision up to the $599.95 Body Scan 2, so it is possible to build into the ecosystem incrementally.
The app does the heavy lifting in terms of connecting data from different devices, and the cardiologist review service adds a real clinical layer that most consumer health platforms do not offer. For buyers comparing connected health devices, Withings remains one of the few brands that combines design quality, clinical validation, and a full ecosystem in one place.
Stay ahead of the curve, explore our full Gadgets coverage.
